Incyte, Macrogenics in $900-Million Immuno-Oncology Deal
By
Incyte Corporation, a Wilmington, Delaware-based biopharmaceutical company, and MacroGenics, a Rockville, Maryland-based clinical-stage biopharmaceutical company, have signed a license agreement worth up to $900 million for MacroGenics’ MGA012, an investigational…
Catalent Completes $950-Million Acquisition of Cook Pharmica
By
Catalent has completed its previously announced $950-million acquisition of Cook Pharmica, a Bloomington, Indiana-based contract development and manufacturing organization of biologic-based drug substances and parenteral drug products. Catalent agreed to…
Almac Group Announces Successful MHRA Inspection at Charnwood Facilities
By
Almac Group, a Craigavon, Ireland-based contract development and manufacturing organization, has successfully completed an inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) of its new pharmaceutical development…